Which medication is not typically used to prevent relapse in multiple sclerosis?

Prepare efficiently for the USMLE Step 2 with our Antibiotics and Treatments Exam. Explore detailed questions, gain insights with comprehensive explanations, and boost your confidence for success! Ace your exam!

Ciprofloxacin is an antibiotic primarily used for treating bacterial infections. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial replication. Due to its mechanism of action targeting bacterial pathogens, it has no role in the management of multiple sclerosis (MS) or in preventing disease relapse.

In contrast, glatiramer is a disease-modifying therapy that functions by mimicking myelin basic protein, thus modulating immune responses against myelin and reducing relapse rates. Beta-interferons are also immunomodulatory agents used to decrease the frequency and severity of relapses by reducing inflammation and enhancing neuronal protection. Fingolimod acts by retaining lymphocytes in lymph nodes, preventing them from contributing to CNS inflammation, and subsequently reducing relapses in MS patients.

Thus, while glatiramer, beta-interferons, and fingolimod are focused on modifying the course of MS and preventing relapse, ciprofloxacin does not have a role in treating or preventing the condition.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy